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Artificial Intelligence and Technology in Health Care:  
Overview and Possible Legal Implications 
 
Sarah Kamensky* 
 
I. Introduction 
 
 The chief concerns in the health care system in the United States today are cost, quality, 
and access to care.1  In an effort to improve our health care system, innovators have begun to 
develop technology and artificial intelligence to aid in reaching these goals.2  In a health care 
setting, artificial intelligence can be used to improve the efficiency and quality of patient care, as 
well as advancing medical research.3  Today, approximately 86% of health care providers utilize 
at least one form of artificial intelligence in their practices. However, under traditional tort liability 
it remains unclear as to the possible legal implications and liability in the event of medical error 
involving artificial intelligence technology.4   The use of artificial intelligence technology in a 
medical setting will inevitably create risks since not all of the possible consequences of the use of 
the new technology are foreseeable.5  There is currently limited information as to legal implications 
for tort liability for error involving artificial intelligence in medical settings since both the 
 
*Sarah Kamensky is a third-year law student at DePaul University College of Law and will receive her J.D. Degree 
in May of 2020. She will receive a certificate in Health Law upon graduation and is currently a member of the 
DePaul Journal of Health Care Law. 
1 Concerns over improving the cost, quality, access, and choice of care are increasingly reflected in today’s health 
care systems in the United States. Ongoing attempts to reform health care systems have focused on these concepts, 
while transforming health care delivery and payment systems with the aim of meeting these goals. BARRY R. 
FURROW ET AL., HEALTH LAW: CASES, MATERIALS, AND PROBLEMS 1 (W. Acad. Publ’g, 8th ed. 2018); see also 
How AI-based Systems Can Improve Medical Outcomes, KNOWLEDGE@WHARTON (Dec. 12, 2018), 
http://knowledge.wharton.upenn.edu/article/ai-based-systems-can-improve-medical-outcomes/.  
2 Hannah R. Sullivan & Scott J. Schweikart, Are Current Tort Liability Doctrines Adequate for Addressing Injury 
Caused by AI?, 21 AMA J. ETHICS 160, 160 (2019).  
3 W. Nicholson Price II, Artificial Intelligence in Health Care: Applications and Legal Implications, 14 
SCITECHLAW 10, 10 (2017).  
4 Sullivan & Schweikart, supra note 2, at 160, 162, 164. 
5 Chris Reed, How Should we Regulate Artificial Intelligence?, ROYAL SOC’Y PUBL’G, Apr. 29, 2018, at 1 
https://royalsocietypublishing.org/doi/pdf/10.1098/rsta.2017.0360. 
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technology and usage are still developing themselves; however, traditional tort liability laws may 
be applicable.6 
 
II. Overview 
 Today, highly intelligent machines and sophisticated robots are performing complex tasks 
that were once thought to only be within the exclusive ability of humans.7  This partnership of 
humans with technology is being realized in many tangible ways and is evident in health care 
settings today through the use of artificial intelligence technology in providing patient care.8  In 
general, artificial intelligence uses technology, along with programmed computer systems, to 
accomplish specific tasks by processing large amounts of data and recognizing patterns within the 
data.9  This form of technology makes it possible for machines to “learn from experience” so that 
they can perform human-like tasks.10  In a health care setting, artificial intelligence refers to the 
use of artificial intelligence technology and automated processes to diagnose and treat patients 
who require care.11  Artificial intelligence relies on the power of predictive algorithms, which 
guide health care professionals in their practice of medicine.12   
The mechanisms that give rise to the recommendations made by the predictive algorithms 
are currently undiscoverable and unknown due to the way that the algorithms calculate their 
 
6 Sullivan & Schweikart, supra note 2, at 160 (explaining that given the limited information regarding tort liability 
involving artificial intelligence in medicine, traditional tort liability laws may be applicable. “Liability for medical 
errors falls under tort law. A tort is a civil claim in which a party requests damages for injuries caused by a harmful, 
wrongful act of another. Typical tort claims in the realm of medicine and health include medical malpractice 
(negligence), respondeat superior (vicarious liability), and products liability.”).  
7 David C. Vladeck, Machines Without Principals: Liability Rules and Artificial Intelligence, 89 WASH. L. REV. 
117, 120 (2014).   
8 Id. at 118.  
9 Jim Goodnight, Artificial Intelligence: What it is and why it matters, SAS, 
https://www.sas.com/en_us/insights/analytics/what-is-artificial-intelligence.html (last visited Mar. 8, 2020).  
10 Id.  
11 Artificial Intelligence in Medicine, MENDELEY (July 2, 2018), 
https://www.mendeley.com/careers/article/artificial-intelligence-in-medicine/.  
12 Sullivan & Schweikart, supra note 2, at 160.  
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“reasoning”.13  This is often referred to as “black-box” artificial intelligence.14  The “neural 
networks” behind the algorithms in black-box artificial intelligence are structured based on the 
human brain, so that the neural networks can self-teach, make decisions, and provide accurate 
responses.15  Despite the ability of this technology to provide accurate responses, and aid in 
improving the cost, access, and quality of patient care, the algorithms by which the technology 
operates have the potential to “become less intelligible to users and even the developers who 
originally programmed the technology.”16  This means that the artificial intelligence technology 
will not be able to demonstrate how it formed its conclusions.17  This can become problematic in 
a medical setting since artificial intelligence cannot explain its decision-making process in the 
same way that a physician or health care provider would.18  Even if the algorithm can give some 
explanation as to how the technology came to its conclusion, it will likely not have a useful 
meaning in medical terms.19  Additionally, the algorithms will become even more complex when 
more data is made available, which refines future predictions made by the algorithms, but also 
causes the algorithms to change over time.20  
 
 
 
 
13 Id.  
14 Id.; see also W. Nicholson Price II, Black-Box Medicine, 28 HARV. J.L. & TECH. 419, 421 (2015).  
15 Sullivan & Schweikart, supra note 2, at 160. 
16 Id. at 160–61; see also Shailin Thomas, Artificial Intelligence and Medical Liability (Part II), BILL HEALTH (Feb. 
10, 2017), http://blog.petrieflom.law.harvard.edu/2017/02/10/artificial-intelligence-and-medical-liability-part-ii/. 
17 Price, supra note 3.  
18 Id. at 11.  
19 Id. at 10 (explaining that either algorithms cannot explain their outcomes at all, or accurate explanations can be 
provided that will be useless in medical understanding. This field is referred to as “black-box medicine,” although it 
has also been referred to as “predictive analytics” or “AI in medicine” due to the inherent opacity of the technology. 
The inherent opacity of the algorithms may or may not be “augmented with deliberate secrecy” based on how the 
algorithms were developed and validated).  
20 Id.  
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III. Artificial Intelligence and Black-Box Medicine 
  Artificial intelligence technology in the form of “black-box” medicine is already being 
utilized in health care systems in many capacities, and has the potential to provide substantial 
benefits to patients.21  These automated processes not only aid in the diagnosis and treatment of 
patients, but also are gaining importance in the background processes that must take place in order 
for a patient to be properly treated.22  Arguments have been made that the use of these forms of 
technology allow tasks to be completed more quickly, while also allowing health care providers to 
treat patients more efficiently.23   
Artificial intelligence is currently being used to process and analyze patients’ test results, 
gather data through patient interviews, use data to determine appropriate diagnoses, and to present 
options for treatment methods while also monitoring patients after suitable treatments have been 
administered.24  For example, a “decision support system” developed at the Laboratory of 
Computer Science at the Massachusetts General Hospital, DXplain, offers the health care provider 
a list of possible diagnoses after the symptoms are input in DXplain’s computer system.25  DXplain 
 
21 Id.; see also Price, supra note 14, at 421 (“Black box medicine, pursued by geneticists, personalized medicine 
advocates, and other health care innovators, already does and increasingly will use the combination of largescale 
high-quality datasets with sophisticated predictive algorithms to identify and use implicit, complex connections 
between multiple patient characteristics. A defining feature of black box medicine is that those algorithms are 
nontransparent — that is, the relationships they capture cannot be explicitly understood, and sometimes cannot even 
be explicitly stated. Note that this type of medicine is ‘black box’ to everyone by nature of its development; it is not 
‘black box’ because its workings are deliberately hidden from view.”).    
22 MENDELEY, supra note 11.   
23 Id. (“The potential for increased AI usage in medicine is not just in a reduction of manual tasks and the freeing up 
of physician’s time, increasing efficiency and productivity — it also presents the opportunity for us to move towards 
more ‘precision medicine.’”).  
24 Id.; see also Shailin Thomas, Artificial Intelligence, Medical Malpractice, and the End of Defensive Medicine, 
BILL HEALTH (Jan. 26, 2017), http://blog.petrieflom.law.harvard.edu/2017/01/26/artificial-intelligence-medical-
malpractice-and-the-end-of-defensive-medicine/. 
25 DXplain: Using Decision Support to Help Explain Clinical Manifestations of Disease, MASS. GEN. HOSP. LAB. 
FOR COMPUT. SCI., http://www.mghlcs.org/projects/dxplain/ (last updated 2017) (“The current DXplain knowledge 
base includes over 2400 diseases and over 5000 clinical findings (symptoms, signs, epidemiologic data and 
laboratory, endoscopic and radiologic findings). The average disease description includes 53 findings, with a range 
from 10 to over 100. Each disease/finding pair has two attributes describing the relationship: one representing the 
frequency with which the finding occurs in the disease and the other the degree to which the presence of the finding 
suggests consideration of the disease. There are over 230,000 individual data points in the knowledge base 
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uses appropriate data to determine diagnoses by using its knowledge base of diseases and clinical 
findings.26  This is an example of “machine learning techniques”, a subset of artificial intelligence, 
that uses basic learning rules to find patterns in vast amounts of data.27   
With the rise of vast quantities of data combined with the need to have fast access to the 
data, medicine is now experiencing a need for technology and artificial intelligence containing 
machine learning techniques in order to reach the above mentioned goals of improving the cost, 
access, and quality of medical care.28  DXplain is just one example of a machine learning technique 
currently used in medicine.29  A laboratory information system, Germwatcher, is another machine 
learning technique currently used in medicine to “detect, track, and investigate infections in 
hospitalized patients.”30   
In addition to machine learning techniques, artificial intelligence is currently being used in 
medicine in other forms such as robotic systems.31  One of the more common robotic systems 
currently used in medicine is the da Vinci robotic surgical system.32  The robotic arms of the 
surgical system allow surgeons to perform precise movements that would not be possible with an 
entirely manual approach, thus allowing the quality of care in certain types of surgeries to be 
improved by utilizing the da Vinci robotic surgical system.33   
 
representing disease/finding relationships. In addition, each finding has an associated disease-independent term 
importance indicating how important it is to explain the presence of the finding.”). 
26 Id.  
27 Price, supra note 3. 
28 MENDELEY, supra note 11. 
29 MASS. GEN. HOSP. LAB. FOR COMPUT. SCI., supra note 25. 
30 MENDELEY, supra note 11. 
31 Id.  
32 About da Vinci Systems, INTUITIVE (2019), https://www.davincisurgery.com/da-vinci-systems/about-da-vinci-
systems (“The da Vinci System is powered by robotic technology that allows the surgeon’s hand movements to be 
translated into smaller, precise movements of tiny instruments inside the patient’s body. One of the instruments is a 
laparoscope — a thin tube with a tiny camera and light at the end. The camera sends images to a video monitor in 
the operating room to guide doctors during surgery. The surgeon is 100% in control of the da Vinci System at all 
times. The da Vinci System has brought minimally invasive surgery to more than 3 million patients worldwide.”).   
33 Id.; see also MENDELEY, supra note 11. 
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As illustrated by these specific examples, artificial intelligence already does aid in 
improving the quality and access to health care, and has the potential to continue to provide 
significant developments in the field of medicine; however, this substantial potential comes with 
medical, technical, and legal challenges.34  Artificial intelligence in medicine must be safe and 
effective, and the question becomes how to protect and provide recourse to patients while ensuring 
the efficient development and continuing use of artificial intelligence technology in medicine.35 
 
IV. Decision Making with Artificial Intelligence 
 Artificial intelligence and machine learning algorithms will continue to make significant 
impacts in decision-making processes, diagnoses, and the treatment of patients in health care 
systems.36  The connections of these algorithms with patient data allow health care providers to 
“increase the precision and accuracy of their diagnoses and decisions” so that they are able to 
identify illness and treat patients with more exactness and accuracy than ever before.37  According 
to Shailin Thomas in Artificial Intelligence, Medical Malpractice, and the End of Defensive 
Medicine, the introduction of artificial intelligence “to medical diagnosis and decision-making has 
the potential to greatly reduce the number of medical errors and misdiagnoses – and allow 
diagnosis based on physiological relationships we don’t even know exist.”38  However, predictions 
based on the complex connections between a patient’s data and the recommended treatment are 
 
34 Price, supra note 3. 
35 Id.; see also Thomas, supra note 24.  
36 Id. 
37 Price, supra note 14 (explaining that this is also known as black-box medicine, “a version of personalized 
medicine in which researchers use sophisticated algorithms to examine huge troves of health data, finding complex, 
implicit relationships and making individualized assessments for patients. This new form of medicine offers 
potentially immense benefits but faces major hurdles both in development and in application  
. . . . [B]lack-box medicine also raises significant challenges with respect to privacy, regulation, and 
commercialization.”). 
38 Thomas, supra note 24.   
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often given with little to no explanation.39  When such dependence in decision making is placed 
on an algorithm, potential malpractice claims become complicated due to the reliance on artificial 
intelligence and the lack of an explanation that it provides for its decisions.40  When a physician 
pursues an improper diagnosis or treatment based on the reliance on artificial intelligence and 
machine learning algorithms, it becomes somewhat unclear who should be responsible when an 
error occurs.41 
 
V. Current Tort Liability Laws Applied to Artificial Intelligence 
Our current tort liability laws may not be sufficient to apply to medical error resulting from 
decisions made by artificial intelligence.42 The main source of concern in determining liability for 
these errors stems from the fact that we as humans cannot “see” the reasoning made by the artificial 
intelligence technology.43  Questions then arise as to whether traditional products liability laws 
should apply, holding the manufacturer of the technology liable, or if the health care provider 
treating the patient by way of using artificial intelligence should be held liable for errors.44   
Typically, liability for medical errors falls under a negligence framework.45  Tort liability 
law in general, including liability for medical errors, typically serves the purpose of compensating 
 
39 Id.   
40 Sullivan & Schweikart, supra note 2, at 160 (explaining that as capabilities of predictive algorithms improve, 
“machine learning will become an important element of physician practice and patient care. Implementation of 
artificial intelligence raises complex legal questions regarding health care professionals’ and technology 
manufacturers’ liability, particularly if they cannot explain recommendations generated by AI technology.”).  
41 Id.   
42 Vladeck, supra note 7, at 121.  
43 Vijay Pande, Artificial Intelligence’s ‘Black Box’ Is Nothing to Fear, N.Y. TIMES (Jan. 25, 2018), 
https://www.nytimes.com/2018/01/25/opinion/artificial-intelligence-black-box.html (clarifying that artificial 
intelligence cannot explain how it comes to its conclusions in the same way that a “human doctor would” when 
making a diagnosis. For example, when a physician makes a diagnosis, he or she will be capable of explaining how 
she reached that conclusion to the patient. If the same diagnosis were made using artificial intelligence, then it 
would be a diagnosis made with “a direct connection to the data” rather than “human intuition based on limited 
data.”).  
44 Id.  
45 Id.; see also Negligence, BLACK’S LAW DICTIONARY (10th ed. 2014) (defining negligence as “the failure to 
exercise the standard of care that a reasonably prudent person would have exercised in a similar situation; any 
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injured parties and deterring unreasonably dangerous conduct.46  Courts have typically enforced 
the standards of practice that the medical profession sets through tort lawsuits.47  When there is a 
case involving medical error, physician liability is determined based on the notion of the physician 
as a trusted expert.48  This means that the treating physician is entirely accountable for his or her 
decisions, and thus if the care provided is determined to be reckless or negligent, then the physician 
will be held responsible.49   
Standards also evolve over time based on advances in medical research and technology. In 
judicial determinations for tort claims involving medical error, expert testimony relating to 
customary practices in the specific field of medicine become important.50  While these standards 
typically evolve through the practices of health care providers, the standard of care can also be 
influenced by practice guidelines set in place by professional medical organizations or legislative 
action.51  While artificial intelligence technology and machine learning algorithms currently used 
in medicine are continuously developing, standards of care involving artificial intelligence are still 
 
conduct that falls below the legal standard established to protect others against unreasonable risk of harm, except for 
conduct that is intentionally, wantonly, or willfully disregardful of other’s rights; the doing of what a reasonable and 
prudent person would not do under the particular circumstances, or the failure to what such a person would do under 
the circumstances.”). 
46 B. Sonny Bal, An Introduction to Medical Malpractice in the United States, 467 CLINICAL ORTHOPEDICS & 
RELATED RES., 339, 340 (2009). 
47 FURROW ET AL., supra note 1, at 218 (“Defendants trying to prove a standard of care normally present expert 
testimony describing the actual pattern of medical practice without any reference to the effectiveness of that 
practice. Courts have traditionally given professional medical standards conclusive weight so that the trier of fact is 
not allowed to reject the practice as improper.”); see, e.g., Doe v. Am. Red Cross Blood Serv., 377 S.E.2d 323, 328 
(S.C. 1989) (concluding that a medical professional cannot be found liable as a matter of law if the plaintiff cannot 
demonstrate that the medical professional failed to conform to the generally recognized practices in his or her 
profession).  
48 Thomas, supra note 24.  
49 Id.  
50 Sullivan & Schweikart, supra note 2, at 160–61.  
51 W. Nicholson Price II, Medical Malpractice and Black Box Medicine, at 9 (U. Mich. Pub. L. & Legal Theory Res. 
Paper Series, Paper No. 536, 2017).  
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evolving. Therefore, customs have not been established as they have been for more traditional 
medical techniques and practices.52   
Additionally, it becomes challenging to apply the current standards used to determine 
physician liability in cases of error involving artificial intelligence technology when the error has 
occurred due to the technology and not necessarily the physician.53  The algorithms used in the 
artificial intelligence technology currently used in medicine are beginning to have higher accuracy 
rates than physicians.54 Thus, it can become difficult to continue to solely hold the physician liable 
and to apply a traditional negligence framework to medical error involving artificial intelligence 
because the physician should not necessarily be blamed for following the algorithms and/or 
artificial intelligence technology.55 However, the counterargument becomes that artificial 
intelligence technology that is used primarily as an aid to health care providers in decision-making 
allows the final decision in terms of diagnosis or treatment to always rest in the hands of the 
provider.56  In these scenarios, traditional tort liability theories may be applicable since the decision 
making will arguably be primarily made by the provider and not the artificial intelligence 
technology.57   
VI. Applying Current Legal Doctrines to Artificial Intelligence  
 
52 Id. 
53 Thomas, supra note 24 (explaining that if algorithms have “a higher accuracy rate than the average doctor — as 
many soon will — it seems wrong to continue to place blame on the physician. Going with the algorithm’s 
suggestion would always be statistically the best option — so it’s hard to argue that a physician would be negligent 
in following the algorithm, even if it turns out to be wrong and the doctor ends up harming a patient. As algorithms 
improve and doctors use them more for diagnosing and decision-making, the traditional malpractice notions of 
physician negligence and recklessness may become harder to apply.”).   
54 Id. 
55 Id. 
56 Vladeck, supra note 7, at 121. 
57 Id.; see also Johan Ordish, Legal liability for machine learning in healthcare, PHG FOUND. (Aug. 2018) 
https://www.phgfoundation.org/documents/briefing-note-legal-liability-for-machine-learning-in-healthcare.pdf (“If a 
patient is harmed by a faulty diagnosis, the most obvious response is to sue the clinician, or most probably their 
employer. This remains true even where software may have contributed to this faulty diagnosis. This is because in 
many jurisdictions, the case law has developed in relation to software used to support rather than make clinical 
decisions.”). 
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Questions still surface when medical error arises due to malfunctions of the artificial 
intelligence technology.58  Our current legal doctrines apply to the conduct of humans, so it is still 
unclear as to how the doctrines will apply to artificial intelligence technology if it is functioning 
in a more autonomous capacity or if the decision-making does not rest entirely in the hands of the 
medical provider.59  Some argue that it is not entirely fair for providers to be solely held liable for 
errors or malfunctions of artificial intelligence technology and machine learning algorithms, 
especially when the technology is functioning by more autonomous means under the provider’s 
supervision.60 Hence, other types of tort liability theories could be applicable to artificial 
intelligence in medicine such as products liability and vicarious liability theories when a traditional 
negligence framework for physician liability and medical error may not apply.61  
 
VII. Vicarious Liability and The Use of Artificial Intelligence 
One possibility is the application of the doctrine of respondeat superior to place vicarious 
liability on the employer of the physician.62 If a physician is acting within the scope of his or her 
employment and simultaneously commits a negligent act involving the use of artificial intelligence 
technology or machine learning algorithms, then the employer of the physician can potentially be 
 
58 Price, supra note 14, at 441.  
59 Yavar Bathaee, The Artificial Intelligence Black Box and the Failure of Intent and Causation, 31 HARV. J.L. 
TECH. 889, 894 (2018).  
60 As Shailin Thomas describes in her article, there are emerging theories that if there is a decrease in associated 
malpractice liability with the use of artificial intelligence and machine learning algorithms, then doctors may also be 
able reduce the amount of defensive medicine that they currently practice, leading to reductions in cost in the 
provision of health care. Thomas, supra note 24 (explaining that it is hoped that “as these algorithms proliferate and 
improve, doctors will begin to rely on their superior accuracy and precision, and the associated decrease in 
malpractice liability will allow those doctors to forego ordering every conceivable test or treatment.”).  
61 Bal, supra note 46, at 345.   
62 Id.; see also Sanchez v. Unified Sch. Dist., 339 P.3d 399, 407–08 (Kan. Ct. App. 2014) (“Under the doctrine of 
respondeat superior, an employer may be held liable to a third person for injuries caused by the negligence of an 
employee if the employee is acting within the scope of employment. An employer is generally relieved of liability 
under a theory of respondeat superior when a legal or factual determination has been made that the employee did not 
act negligently. Statutory immunity from liability granted by the legislature to an employee is personal to the 
employee and, in the absence of a clear legislative statement to the contrary, does not shield the employer from 
liability under a theory of respondeat superior.”). 
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held liable for their wrongdoing.63  Under this theory, health care providers and hospitals may also 
be held negligent for failing to properly train and/or supervise employees in the use of the artificial 
intelligence technology if an error were to occur.64  It has additionally been questioned whether 
health care providers and hospitals themselves must evaluate the quality of the artificial 
intelligence technology and machine learning algorithms before physicians use them in the course 
of treating their patients.65  Courts have not addressed this issue yet, as the technology is still 
developing, and the information to make such a determination is largely unavailable at this time.66  
Currently, it is still unclear how courts will apply vicarious liability doctrines to the use of artificial 
intelligence in medicine.67 
VIII. Products Liability Laws Applied to Artificial Intelligence 
 Under current products liability laws, the manufacturers and creators of the artificial 
intelligence technology and machine learning algorithms that are currently being used in medicine 
 
63 Id.; see also Far W. Fin. Corp. v. D & S Co., 760 P.2d 399, 410–11 (Cal. 1988) (“As a leading text on torts 
explains, the modern justification for vicarious liability closely parallels the justification for imposing liability on the 
nonnegligent manufacturer of a product: ‘What has emerged as the modern justification for vicarious liability is a 
rule of policy, a deliberate allocation of risk. The losses caused by the torts of employees, which as a practical matter 
are sure to occur in the conduct of the employer’s enterprise, are placed upon that enterprise itself, as a required cost 
of doing business. They are placed upon the employer because, having engaged in an enterprise, which will on the 
basis of all past experience involve harm to others through the torts of employees and sought to profit by it, it is just 
that he, rather than the innocent plaintiff, should bear them; and because he is better able to absorb them, and to 
distribute them, through prices, rates or liability insurance, to the public, and so to shift them to society, to the 
community at large.’” (citing PROSSER & KEETON ON TORTS § 69, p. 500 (5th ed. 1984))).  
64 Sullivan & Schweikart, supra note 2, at 162. 
65 Price, supra note 14, at 420, 430.  
66 Id. at 449 (explaining that even though the algorithms can potentially perform “the usual analyses more quickly 
and cheaply” than providers could without the use of the technology, “excessive caution” will likely still be used 
since courts have not tackled these issues of liability surrounding the use of artificial intelligence in medicine).  
67 Id. (clarifying that questions arise when determining what healthcare providers and healthcare institutions must do 
to fulfill their duties of care to patients in health care systems that use artificial intelligence technology and machine 
learning algorithms. Some of these questions include: “Must providers themselves evaluate the quality of black-box 
algorithms, based on procedural measures (validation undertaken, performance statistics, etc.) before relying on 
those algorithms in the course of providing care? And should healthcare institutions perform similar evaluations 
before implementing black-box software?” Currently, the information needed to make these types of evaluations and 
answer these questions is mostly unavailable).  
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may potentially be liable if an error involving the technology occurs.68  Liability could exist based 
on the products liability principle that if the product, the artificial intelligence technology, causes 
harm, then that harm is implied proof of some defect within the technology.69  
The idea of imposing liability on the manufacturer is based on the reasoning that the creator 
must pay for any harm caused by the technology.70  Arguably then, the creator is in the best place 
to develop the artificial intelligence technology so that it is safe and will prevent harm to users.71  
The creator and/or manufacturer will also be in the best position to “absorb any economic losses 
stemming from the harm.”72  Medical devices and technology have at times been categorized by 
courts as “unavoidably unsafe products”, meaning that they are made in a way that makes them 
incapable of being completely safe.73 A negligence standard will then be applied to a design that 
is considered defective under the products liability doctrines.74  This negligence standard “focuses 
on the conduct of the manufacturer to use reasonable care to design…a product that is reasonably 
safe.”75  The standard of “reasonable care” is then decided based on what the manufacturer knew 
or reasonably should have known at the time that the plaintiff was injured by the product.76  Even 
 
68 Matthew O. Wagner, You Can’t Sue a Robot: Are Existing Tort Theories Ready for Artificial Intelligence?, FROST 
BROWN TODD (Feb. 7, 2018), https://www.frostbrowntodd.com/resources-you-cant-sue-a-robot-are-existing-tort-
theories-ready-for-artificial-intelligence.html. 
69 Id.  
70 Payne v. Paugh, 360 P.3d 39, 50 (Wash. App. Div. 1 2015).  
71 Id. 
72 Wagner, supra note 68.  
73 Payne, 360 P.3d at 50. 
74 Id.; see also RESTATEMENT (SECOND) OF TORTS § 402A cmt. k (AM. LAW INST. 1965) (describing the concept of 
an “unavoidably safe product,” such as a medical device or a prescription drug, for purposes of product liability law 
and establishes an exception to strict liability for unavoidably unsafe products). 
75 Payne, 360 P.3d at 53.  
76 Id. at 53–54 (determining whether a manufacturer has exercised reasonable care, the court in Payne instructed that 
the trier of fact must consider that a medical device manufacturer (1) “has a duty to use reasonable care to test, 
analyze, and inspect the products it sells, and is presumed to know what such tests would have revealed” and (2) 
“has a duty to use reasonable care to keep abreast scientific knowledge, discoveries, advances, and research in the 
field and is presumed to know what is imparted thereby.”); see also RESTATEMENT (SECOND) OF TORTS § 402A cmt. 
k (AM. LAW INST. 1965) (“[A] trier of fact must consider that a medical device manufacturer (1) has a duty to use 
reasonable care to test, analyze, and inspect the products it sells and is presumed to know what such tests would 
have revealed and (2) has a duty to use reasonable care to keep abreast scientific knowledge, discoveries, advances, 
and research in the field and is presumed to know what is imparted thereby.”).  
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though these standards have historically been applied by courts to medical devices, prescriptions, 
and their respective manufacturers, applications to artificial intelligence technology and the 
machine learning algorithms currently used in medicine are feasible.77   
Application of a products liability theory to artificial intelligence can be complicated. A 
designer of artificial intelligence technology cannot necessarily foresee how the technology will 
act once it is being used in a real world medical setting.78  Therefore, it can be unfair to assign 
blame to one person whose work was far removed from the actual operation of the technology in 
a medical setting.79  So many entities and individuals, such as designers, engineers, and developers, 
work together to create artificial intelligence technology and systems.80  This makes it especially 
difficult to blame one individual.81  Moreover, arguments have been made that applying strict 
liability under traditional products liability doctrines will be too difficult since the algorithms in 
the artificial intelligence technology currently being used in medicine are characteristically 
imperfect.82  For example, an algorithm developed by researchers at Stanford has an accuracy rate 
 
77 Price, supra note 21, at 457; see also Price, supra note 3, at 11. 
78 Sullivan & Schweikart, supra note 2, at 162–63.  
79 Id. at 163. 
80 Id.; see also Wagner, supra note 68. 
81 Sullivan & Schweikart, supra note 2, at 163; see also Wagner, supra note 68. 
82 Thomas, supra note 16 (“Traditional products liability doctrine applies strict liability to most consumer products. 
If a can of soda explodes and injures someone, the company that produced it is liable, even if it didn’t do anything 
wrong in the manufacturing or distribution processes. Strict liability works well for most consumer products but 
would likely prove too burdensome for medical algorithms. This is because medical algorithms are inherently 
imperfect. No matter how good the algorithm is — or how much better it is than a human physician — it will 
occasionally be wrong. Even the best algorithms will give rise to potentially substantial liability some percentage of 
the time under a strict liability regime.”). 
83 Id. (referring to a research study performed by researchers at Stanford who “developed an algorithm that can 
diagnose melanomas as well as or better than expert dermatologists.” It is also important to note that the study 
claims that “as the algorithm improves, it could become an important part of identifying melanomas as early and 
often as possible.”); see also Andre Esteva et al., Dermatologist-Level Classification of Skin Cancer with Deep 
Neural Networks, 542 NATURE INT’L J. SCI. 115, 115 (2017) (“Skin cancer, the most common human malignancy, is 
primarily diagnosed visually, beginning with an initial clinical screening and followed potentially by dermoscopic 
analysis, a biopsy and histopathological examination. Automated classification of skin lesions using images is a 
challenging task owing to the fine-grained variability in the appearance of the skin lesions. Deep convolutional 
neural networks (CNNs), show potential for general and highly variable tasks across many fine-grained object 
categories.”). 
84 Id. 
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of less than 75%.83  Even though this technology will likely be of benefit to the medical 
community, it would impose liability each time a patient is inevitably misdiagnosed based on its 
accuracy rate under a strict liability theory.84  Imposing strict liability in this example would not 
be beneficial since the production of this technology would likely slow down or cease completely 
if such sure and immediate liability was imminent.85  This would be a setback for the medical 
community since the full potential of the use of artificial intelligence technology and machine 
learning algorithms would never be fully realized if development and production decreased or 
stopped due to fear of the imposition of liability.86  This is why some argue that strict liability 
could be avoided altogether if an “unavoidably unsafe products” approach were to be applied, as 
previously mentioned.87  However, questions then arise relating to the duty to warn under an 
unavoidably unsafe products approach.88  Under this approach, a manufacturer would have to rely 
on a learned intermediary to warn the ultimate user of the manufacturer’s product.89  For example, 
 
85 Id. 
86 Wagner, supra note 68.  
87 Id. 
88 Sullivan & Schweikart, supra note 2, at 162; see also Thomas, supra note 16. 
89 Sullivan & Schweikart, supra note 2, at 162; see also Conley v. Lift-All Co., No. 1:03-CV-1200-DFH-TAB, 2005 
WL 1799505, at *9 (S.D. Ind. July 25, 2005) (considering RESTATEMENT (SECOND) OF TORTS § 388, cmt. n (AM. 
LAW INST. 2012), in determining whether a manufacturer has satisfied a duty to warn by relying on a learned 
intermediary. RESTATEMENT (SECOND) OF TORTS § 388, cmt. n (AM. LAW INST. 2012), considers the “likelihood or 
unlikelihood that harm will occur if the intermediary does not pass on the warning to the ultimate user, the trivial 
nature of the probable harm, the probability or improbability that the particular intermediary will not pass on the 
warning, and the ease or burden of the giving of the warning by the manufacturer to the ultimate user . . . . [In 
addition], the manufacturer’s reliance on the intermediary’s alleged sophistication may be more or less reasonable 
given the product’s nature, complexity and associated dangers, the likelihood that the intermediary will 
communicate warnings to the ultimate consumer, the dangers posed to the ultimate consumer by an inadequate or 
nonexistent warning, and the feasibility of requiring the manufacturer to directly warn the product’s ultimate 
consumers.”).   
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the manufacturer or developer of the artificial intelligence technology would need to rely on the 
health care provider to warn the patient of the potential risks associated with utilizing the 
technology.90  Liability for pharmaceuticals and medical device manufacturers is often determined 
by utilizing this method, but it likely would not be as easily applied to the use of artificial 
intelligence technology in medicine.91 First, because of the way that the artificial intelligence 
technology is tested before use, all of the potential risks or complications that may arise from its 
usage will likely be discovered.92  This means that the probability of an unknown error occurring 
is not likely.93 Second, since the algorithms are designed to be very accurate, an unavoidably 
unsafe products approach likely will not apply to the use of artificial intelligence in medicine in 
the same way that it applies to medical devices or pharmaceuticals.94 
 
IX. Summary 
The use of artificial intelligence technology in a medical setting will unavoidably create 
risks because not all of the possible consequences of the use of the new technology are 
foreseeable.95  As discussed, there is currently limited information as to legal implications for tort 
liability for error involving artificial intelligence in medical settings since the technology and usage 
are still developing themselves.96  Current tort liability laws may be applicable, yet under 
traditional tort liability it remains somewhat unclear as to the possible legal implications in the 
event of medical error involving artificial intelligence technology and machine learning 
algorithms.97   
 
90 Id. 
91 Thomas, supra note 16. 
92 Id. 
93 Id. 
94 Id. 
95 Reed, supra note 5, at 1, 3; see also Price, supra note 3.  
96 Reed, supra note 5, at 1. 
97 Sullivan & Schweikart, supra note 2, at 162–63.   
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Some argue in favor of applying the traditional tort liability theories to artificial intelligence 
used in medicine since there is evidence of the “human hand” involved in machine-based decision 
making.98  Under this theory, a human who helps to develop a piece of artificial intelligence 
technology or helps guide its decision making is potentially “responsible for wrongful acts – 
negligent or intentional – committed by, or involving, the machine.”99  This reasoning is based 
upon the idea that artificial intelligence technology is not fully autonomous, so it cannot be 
considered a “legal person” that may be held accountable under tort law for errors.100  The types 
of artificial intelligence used in medicine today fall within this category since the technology is 
not yet fully autonomous.101  For example, an app that may aid a physician in diagnosing a patient 
and the da Vinci Surgical System, previously mentioned, both function under human supervision 
and with the input of data by humans.102  Artificial intelligence currently used in medicine is not 
fully autonomous in the same way as artificial intelligence technology utilized by driver-less cars 
or fully independent drone aircrafts.103  Therefore, it is feasible for current tort laws to be applied 
to the use of artificial intelligence and machine learning algorithms currently used in medicine 
since there is still evidence of the “human hand” in their usage.104  Also, current products liability 
laws could potentially be applicable.105   
 
98 Vladeck, supra note 7, at 120. 
99 Id. at 120–21.  
100 Id. at 121 (explaining that despite the sophistication of artificial intelligence technology and machines, they have 
no attribute of legal personhood. They are considered “agents or instruments of other entities that have legal 
capacity as individuals, corporations, or other legal ‘persons’ that may be held accountable under the law for their 
actions.”).   
101 Monika Hengstler et al., Applied Artificial Intelligence and Trust – The Case of Autonomous Vehicles and 
Medical Assistance Devices, 105 TECH. FORECASTING SOC. CHANGE 105, 109 (2016).  
102 MENDELEY, supra note 11; see also About da Vinci Systems – Surgical robotics for minimally invasive surgery, 
INTUITIVE, https://www.davincisurgery.com/da-vinci-systems/about-da-vinci-systems (last visited Mar. 8, 2020) 
(“The da Vinci Surgical System enables surgeons to perform operations through a few small incisions and features 
several key features, including . . . wristed instruments that bend and rotate far greater than the human hand.”).  
103 Hengstler et al., supra note 101, at 107. 
104 Vladeck, supra note 7, at 120, 146.   
105 Id. at 130.  
 17 
However several counterarguments to this theory exist since  some argue that it unfair to 
assign blame to those whose work was far removed from the actual use of the artificial intelligence 
technology.106  Imposing strict liability arguably would not be beneficial since the production of 
the artificial intelligence technology would likely slow down or cease completely if such sure and 
immediate liability was imminent under current products liability and strict liability theories.107  
Many fear that this would be a setback for the medical community since the full potential of the 
use of artificial intelligence technology and machine learning algorithms would never be fully 
realized if development and production decreased or stopped due to fear of the imposition of 
liability.108 
 
X. Conclusion 
 Today, artificial intelligence and machine learning algorithms are being used in 
approximately 86% of health care providers’ practices.109  Innovators began to develop these forms 
of artificial intelligence technology in an effort to improve the efficiency and quality of patient 
care, as well as to improve the cost and access to care while at the same time advancing medical 
research.110  Artificial intelligence technology already does aid in improving the quality and access 
to health care and has the potential to continue to provide significant developments in the field of 
medicine; however, this substantial potential comes with medical, technical, and legal 
challenges.111   
 
106 Sullivan & Schweikart, supra note 2, at 161, 163 (explaining that given the limited information regarding tort 
liability involving artificial intelligence in medicine, traditional tort liability laws may be applicable. “Liability for 
medical errors falls under tort law. A tort is a civil claim in which a party requests damages for injuries caused by a 
harmful, wrongful act of another. Typical tort claims in the realm of medicine and health include medical 
malpractice (negligence), respondeat superior (vicarious liability), and products liability.”).    
107 Id. 
108 Thomas, supra note 16.  
109 Price, supra note 3. 
110 Sullivan & Schweikart, supra note 2, at 160.  
111 Price, supra note 3. 
 18 
Concerns arise when questioning how safe and effective artificial intelligence in medicine 
will be, and the issue then becomes how to protect and provide recourse to patients.112 Current tort 
liability theories may be applicable, but information at this time is largely unavailable to make 
evaluations of how exactly how these theories will apply.113  Courts have also not yet addressed 
many of the issues surrounding liability and the usage of artificial intelligence technology and 
machine learning algorithms in medicine.114  In the future the goal will become ensuring the 
efficient development and continuing use of artificial intelligence technology in medicine, but 
these developments may change the way current laws are applied in the context of contemporary 
health care liability issues.115  As artificial intelligence technology continues to develop, courts 
will need to address these potential disputes surrounding the usage of artificial intelligence in 
medicine, and the need for the consideration of issues will likely grow in the future.116 
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